Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Actelsar HCT

Actelsar HCT 40 mg/12.5 mg tablets Actelsar HCT 80 mg/12.5 mg tablets · Abschnitt 4.8 · PDF-Seite 12

HOS-219569 · Präparat HOS-216393

MedDRA Adverse Reactions Frequency System Organ Actelsar Class HCT Telmisartana Hydrochlorothiazide Infections and Sepsis including infestations fatal outcome rare2 Bronchitis rare Pharyngitis rare Sinusitis rare Upper respiratory tract infection uncommon Urinary tract infection uncommon Cystitis uncommon Neoplasms Non-melanoma benign, skin cancer (Basal malignant and cell carcinoma and unspecified (incl. Squamous cell cysts and polyps) carcinoma) not known2 Blood and Anaemia uncommon lymphatic Eosinophilia rare system disorders Thrombocytopenia rare rare Thrombocytopenic purpura rare Aplastic anaemia not known Haemolytic anaemia very rare Bone marrow failure very rare Leukopenia very rare Agranulocytosis very rare Immune system Anaphylactic disorders reaction, rare Hypersensitivity rare very rare Metabolism and Hypokalaemia uncommon very common nutrition Hyperuricaemia rare common disorders Hyponatraemia rare rare common Hyperkalaemia uncommon Hypoglycaemia (in diabetic patients) rare Hypomagnesaemia common Hypercalcaemia rare Alkalosis hypochloraemic very rare Decreased appetite common Hyperlipidaemia very common Hyperglycaemia rare Diabetes mellitus inadequate control rare Anxiety uncommon rare

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.